新生児スクリーニングのアジア太平洋市場予測2019-2027

Inkwood Researchが発行した調査報告書(INKW906165)
◆英語タイトル:ASIA PACIFIC NEW BORN SCREENING MARKET FORECAST 2019-2027
◆商品コード:INKW906165
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2019年3月20日
◆ページ数:90
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アジア太平洋
◆産業分野:
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥133,750見積依頼/購入/質問フォーム
Multi LicenseUSD1,500 ⇒換算¥160,500見積依頼/購入/質問フォーム
Enterprisewide PriceUSD2,000 ⇒換算¥214,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Inkwood Research社の概要及び新刊レポートはこちらでご確認いただけます。

Inkwoodリサーチが調査・発行した本調査レポートでは、新生児スクリーニングのアジア太平洋市場について調べ、新生児スクリーニングの市場動向、市場規模、セグメント別市場規模、主要企業情報などをまとめました。
【レポートの概要】

KEY INSIGHTSThe Asia-Pacific newborn screening market is driven by the support of government organizations promoting the initiatives in the treatment of fatal diseases in the region thereby helping the market to grow at the end of the forecast period of 2019-2027, the market is predicted to rise with a CAGR of 14.17%.
MARKET INSIGHTS
The South Korean newborn screening market contributed the highest CAGR value in 2018 owing to the increasing birth rate coupled with the newborn screening initiatives helping the market to grow in this region. As per the World Health Organization, around 0.48 million babies are born each year in South Korea which is likely to raise the adoption of newborn screening considering the complication that a newborn experiences.
Other significant markets in this region include India, China, Australia and the rest of Asia-Pacific.
Factors like raising awareness for pediatric congenital heart disease and an increase in the number of pregnant women with advanced maternal age are expected to drive the market growth in this region. Newborn screening reagents and assay kits are supposed to be the more popular product category in this market. However, a lack of skilled professionals to safely carry out these screenings is a major challenge faced by this market.
COMPETITIVE INSIGHTS
Market players like Sciex, Biotek Instruments Inc., Bio-Rad Laboratories Inc., Cardinal Health Inc., GE Healthcare Limited, Agilent Technologies Inc., Masimo Corporation, Natus Medical Incorporated, Medtronic PLC, Thermo Fisher Scientific Inc., Neogen Labs Pvt. Ltd., Perkinelmer Inc., Zentech S.A., Waters Corporation and Trivitron Healthcare are well-known in this region.

【レポートの目次】

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP-DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. DEMAND FOR NEWBORN SCREENING INSTRUMENTS IS RISING STEADILY
3.2.2. GROWTH IN DRY BLOOD SPOT TEST
3.2.3. TECHNIQUES USED IN NEWBORN SCREENING TESTS
4. MARKET DYNAMICS
4.1. ETYMOLOGY OF NEWBORN SCREENING
4.2. MARKET SCOPE & DEFINITION
4.3. MARKET DRIVERS
4.3.1. INCREASE IN OCCURRENCES OF NEWBORN DISEASES
4.3.2. GROWING NUMBER OF INFANTS WITH BIRTH DEFECT
4.3.3. BACKING OF GOVERNMENT TOWARDS NEWBORN CHILD HEALTH
4.3.4. RISING AWARENESS FOR PEDIATRIC CONGENITAL HEART DISEASE
4.4. MARKET RESTRAINTS
4.4.1. ABSENCE OF PROPER HEALTHCARE INFRASTRUCTURE FOR NEWBORN BABIES IN DEVELOPING COUNTRIES
4.4.2. SOCIO-ECONOMIC HURDLES IN THE IMPLEMENTATION OF NEWBORN CHILD SCREENING
4.5. MARKET OPPORTUNITIES
4.5.1. INCREASING FERTILITY RATES ACROSS THE GLOBE IS CREATING DYNAMIC GROWTH
4.5.2. NEWBORN SCREENING HELPS IN EARLY IDENTIFICATION AND MANAGEMENT OF AFFECTED NEWBORNS
4.5.3. TECHNOLOGICAL ADVANCEMENTS IN NEWBORN SCREENING
4.5.4. INCREASE IN NUMBER OF PREGNANT WOMEN WITH ADVANCED MATERNAL AGE
4.6. MARKET CHALLENGES
4.6.1. DEARTH OF SKILLED PROFESSIONAL IN HEALTHCARE INDUSTRY
4.6.2. MAINTENANCE OF EQUIPMENT IN HOSPITAL
5. MARKET BY PRODUCT
5.1. NEW-BORN SCREENING INSTRUMENTS
5.2. NEW-BORN SCREENING REAGENTS & ASSAY KITS
6. MARKET BY TEST TYPE
6.1. HEARING SCREEN TEST
6.2. CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST
6.3. DRY BLOOD SPOT TEST
7. MARKET BY TECHNOLOGY
7.1. TANDEM MASS SPECTROMETRY
7.2. PULSE OXIMETRY
7.3. ENZYME BASED ASSAYS
7.4. DNA BASED ASSAYS
7.5. ELECTROPHORESIS
7.6. OTHERS
8. KEY ANALYTICS
8.1. PORTERS FIVE FORCE MODEL
8.1.1. THREAT OF NEW ENTRANTS
8.1.2. THREAT OF SUBSTITUTE
8.1.3. BARGAINING POWER OF SUPPLIERS
8.1.4. BARGAINING POWER OF BUYERS
8.1.5. THREAT OF COMPETITIVE RIVALRY
8.2. KEY BUYING CRITERIA
8.2.1. RELIABILITY
8.2.2. COST
8.2.3. AVAILABILITY
8.2.4. TECHNOLOGICAL ADVANCEMENT
8.3. OPPORTUNITY MATRIX
8.4. VENDOR LANDSCAPE
8.5. VALUE CHAIN ANALYSIS
8.5.1. RAW MATERIAL SUPPLIERS
8.5.2. MANUFACTURERS
8.5.3. DISTRIBUTORS
8.5.4. END-USERS
8.6. LEGAL, POLICY & REGULATORY FRAMEWORK
9. ASIA PACIFIC
9.1. CHINA
9.2. INDIA
9.3. JAPAN
9.4. AUSTRALIA
9.5. SOUTH KOREA
9.6. REST OF ASIA PACIFIC
10. COMPETITIVE LANDSCAPE
10.1. MARKET SHARE ANALYSIS
10.2. CORPORATE STRATEGIES
10.2.1. PRODUCT LAUNCH
10.3. COMPANY PROFILES
10.3.1. SCIEX
10.3.1.1. OVERVIEW
10.3.1.2. PRODUCT PORTFOLIO
10.3.1.3. STRATEGIC INITIATIVES
10.3.1.4. SCOT ANALYSIS
10.3.2. BIOTEK INSTRUMENTS INC
10.3.2.1. OVERVIEW
10.3.2.2. PRODUCT PORTFOLIO
10.3.2.3. STRATEGIC INITIATIVES
10.3.2.4. SCOT ANALYSIS
10.3.3. BIO-RAD LABORATORIES INC
10.3.3.1. OVERVIEW
10.3.3.2. PRODUCT PORTFOLIO
10.3.3.3. STRATEGIC INITIATIVES
10.3.3.4. SCOT ANALYSIS
10.3.4. CARDINAL HEALTH INC
10.3.4.1. OVERVIEW
10.3.4.2. PRODUCT PORTFOLIO
10.3.4.3. STRATEGIC INITIATIVES
10.3.4.4. SCOT ANALYSIS
10.3.5. GE HEALTHCARE LIMITED
10.3.5.1. OVERVIEW
10.3.5.2. PRODUCT PORTFOLIO
10.3.5.3. STRATEGIC INITIATIVES
10.3.5.4. SCOT ANALYSIS
10.3.6. AGILENT TECHNOLOGIES INC.
10.3.6.1. OVERVIEW
10.3.6.2. PRODUCT PORTFOLIO
10.3.6.3. STRATEGIC INITIATIVES
10.3.6.4. SCOT ANALYSIS
10.3.7. MASIMO CORPORATION
10.3.7.1. OVERVIEW
10.3.7.2. PRODUCT PORTFOLIO
10.3.7.3. STRATEGIC INITIATIVES
10.3.7.4. SCOT ANALYSIS
10.3.8. NATUS MEDICAL INCORPORATED
10.3.8.1. OVERVIEW
10.3.8.2. PRODUCT PORTFOLIO
10.3.8.3. STRATEGIC INITIATIVES
10.3.8.4. SCOT ANALYSIS
10.3.9. MEDTRONIC PLC
10.3.9.1. OVERVIEW
10.3.9.2. PRODUCT PORTFOLIO
10.3.9.3. STRATEGIC INITIATIVES
10.3.9.4. SCOT ANALYSIS
10.3.10. THERMO FISHER SCIENTIFIC INC.
10.3.10.1. OVERVIEW
10.3.10.2. PRODUCT PORTFOLIO
10.3.10.3. STRATEGIC INITIATIVES
10.3.10.4. SCOT ANALYSIS
10.3.11. NEOGEN LABS PVT. LTD.
10.3.11.1. OVERVIEW
10.3.11.2. PRODUCT PORTFOLIO
10.3.11.3. STRATEGIC INITIATIVES
10.3.11.4. SCOT ANALYSIS
10.3.12. PERKINELMER INC.
10.3.12.1. OVERVIEW
10.3.12.2. PRODUCT PORTFOLIO
10.3.12.3. STRATEGIC INITIATIVES
10.3.12.4. SCOT ANALYSIS
10.3.13. ZENTECH S.A.
10.3.13.1. OVERVIEW
10.3.13.2. PRODUCT PORTFOLIO
10.3.13.3. STRATEGIC INITIATIVES
10.3.13.4. SCOT ANALYSIS
10.3.14. WATERS CORPORATION
10.3.14.1. OVERVIEW
10.3.14.2. PRODUCT PORTFOLIO
10.3.14.3. STRATEGIC INITIATIVES
10.3.14.4. SCOT ANALYSIS
10.3.15. TRIVITRON HEALTHCARE
10.3.15.1. OVERVIEW
10.3.15.2. PRODUCT PORTFOLIO
10.3.15.3. STRATEGIC INITIATIVES
10.3.15.4. SCOT ANALYSIS

LIST OF TABLES
TABLE 1. ASIA PACIFIC NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
TABLE 2. ASIA PACIFIC INCIDENCE OF CHROMOSOMAL ABNORMALITIES IN NEWBORNS
TABLE 3. INFANT MORTALITY RATE IN DEVELOPING COUNTRIES (TOTAL DEATH/ 1000 LIVE BIRTHS)
TABLE 4. ASIA PACIFIC NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027, (IN $ MILLION)
TABLE 5. ASIA PACIFIC NEWBORN SCREENING MARKET, BY TEST TYPE, 2019-2027, (IN $ MILLION)
TABLE 6. ASIA PACIFIC NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019-2027, (IN $ MILLION)
TABLE 7. OPPORTUNITY MATRIX
TABLE 8. VENDOR LANDSCAPE
TABLE 9. REGULATORY FRAMEWORK
TABLE 10. ASIA PACIFIC NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027, (IN $ MILLION)
TABLE 11. LIST OF PRODUCT LAUNCHES

LIST OF FIGURES
FIGURE 1. ASIA PACIFIC NEW-BORN SCREENING INSTRUMENTS MARKET, BY TECHNOLOGY, 2018 & 2027 (IN %)
FIGURE 2. CAUSES OF DEATH AMONG NEWBORNS ASIA PACIFIC (0-27 DAYS)
FIGURE 3. FERTILITY RATE (AVERAGE BIRTHS PER WOMAN IN %) 2017
FIGURE 4. ASIA PACIFIC NEWBORN SCREENING MARKET, BY NEW-BORN SCREENING INSTRUMENTS, 2019-2027 (IN $ MILLION)
FIGURE 5. ASIA PACIFIC NEWBORN SCREENING MARKET, BY NEW-BORN SCREENING REAGENTS & ASSAY KITS, 2019-2027 (IN $ MILLION)
FIGURE 6. ASIA PACIFIC NEWBORN SCREENING MARKET, BY HEARING SCREEN TEST, 2019-2027 (IN $ MILLION)
FIGURE 7. ASIA PACIFIC NEWBORN SCREENING MARKET, BY CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST, 2019-2027 (IN $ MILLION)
FIGURE 8. ASIA PACIFIC NEWBORN SCREENING MARKET, BY DRY BLOOD SPOT TEST, 2019-2027 (IN $ MILLION)
FIGURE 9. ASIA PACIFIC NEWBORN SCREENING MARKET, BY TANDEM MASS SPECTROMETRY, 2019-2027 (IN $ MILLION)
FIGURE 10. ASIA PACIFIC NEWBORN SCREENING MARKET, BY PULSE OXIMETRY, 2019-2027 (IN $ MILLION)
FIGURE 11. ASIA PACIFIC NEWBORN SCREENING MARKET, BY ENZYME BASED ASSAYS, 2019-2027 (IN $ MILLION)
FIGURE 12. ASIA PACIFIC NEWBORN SCREENING MARKET, BY DNA BASED ASSAYS, 2019-2027 (IN $ MILLION)
FIGURE 13. ASIA PACIFIC NEWBORN SCREENING MARKET, BY ELECTROPHORESIS, 2019-2027 (IN $ MILLION)
FIGURE 14. ASIA PACIFIC NEWBORN SCREENING MARKET, BY OTHERS, 2019-2027 (IN $ MILLION)
FIGURE 15. PORTER’S FIVE FORCE ANALYSIS
FIGURE 16. KEY BUYING IMPACT ANALYSIS
FIGURE 17. VALUE CHAIN ANALYSIS
FIGURE 18. ASIA PACIFIC NEWBORN SCREENING MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)
FIGURE 19. CHINA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 20. INDIA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 21. JAPAN NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 22. AUSTRALIA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 23. SOUTH KOREA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLIONS)
FIGURE 24. REST OF ASIA PACIFIC NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 25. INDUSTRY PLAYER POSITIONING IN 2018 (IN %)

LIST OF TABLES
TABLE 1. ASIA PACIFIC NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
TABLE 2. ASIA PACIFIC INCIDENCE OF CHROMOSOMAL ABNORMALITIES IN NEWBORNS
TABLE 3. INFANT MORTALITY RATE IN DEVELOPING COUNTRIES (TOTAL DEATH/ 1000 LIVE BIRTHS)
TABLE 4. ASIA PACIFIC NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027, (IN $ MILLION)
TABLE 5. ASIA PACIFIC NEWBORN SCREENING MARKET, BY TEST TYPE, 2019-2027, (IN $ MILLION)
TABLE 6. ASIA PACIFIC NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019-2027, (IN $ MILLION)
TABLE 7. OPPORTUNITY MATRIX
TABLE 8. VENDOR LANDSCAPE
TABLE 9. REGULATORY FRAMEWORK
TABLE 10. ASIA PACIFIC NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027, (IN $ MILLION)
TABLE 11. LIST OF PRODUCT LAUNCHES


LIST OF FIGURES
FIGURE 1. ASIA PACIFIC NEW-BORN SCREENING INSTRUMENTS MARKET, BY TECHNOLOGY, 2018 & 2027 (IN %)
FIGURE 2. CAUSES OF DEATH AMONG NEWBORNS ASIA PACIFIC (0-27 DAYS)
FIGURE 3. FERTILITY RATE (AVERAGE BIRTHS PER WOMAN IN %) 2017
FIGURE 4. ASIA PACIFIC NEWBORN SCREENING MARKET, BY NEW-BORN SCREENING INSTRUMENTS, 2019-2027 (IN $ MILLION)
FIGURE 5. ASIA PACIFIC NEWBORN SCREENING MARKET, BY NEW-BORN SCREENING REAGENTS & ASSAY KITS, 2019-2027 (IN $ MILLION)
FIGURE 6. ASIA PACIFIC NEWBORN SCREENING MARKET, BY HEARING SCREEN TEST, 2019-2027 (IN $ MILLION)
FIGURE 7. ASIA PACIFIC NEWBORN SCREENING MARKET, BY CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST, 2019-2027 (IN $ MILLION)
FIGURE 8. ASIA PACIFIC NEWBORN SCREENING MARKET, BY DRY BLOOD SPOT TEST, 2019-2027 (IN $ MILLION)
FIGURE 9. ASIA PACIFIC NEWBORN SCREENING MARKET, BY TANDEM MASS SPECTROMETRY, 2019-2027 (IN $ MILLION)
FIGURE 10. ASIA PACIFIC NEWBORN SCREENING MARKET, BY PULSE OXIMETRY, 2019-2027 (IN $ MILLION)
FIGURE 11. ASIA PACIFIC NEWBORN SCREENING MARKET, BY ENZYME BASED ASSAYS, 2019-2027 (IN $ MILLION)
FIGURE 12. ASIA PACIFIC NEWBORN SCREENING MARKET, BY DNA BASED ASSAYS, 2019-2027 (IN $ MILLION)
FIGURE 13. ASIA PACIFIC NEWBORN SCREENING MARKET, BY ELECTROPHORESIS, 2019-2027 (IN $ MILLION)
FIGURE 14. ASIA PACIFIC NEWBORN SCREENING MARKET, BY OTHERS, 2019-2027 (IN $ MILLION)
FIGURE 15. PORTER’S FIVE FORCE ANALYSIS
FIGURE 16. KEY BUYING IMPACT ANALYSIS
FIGURE 17. VALUE CHAIN ANALYSIS
FIGURE 18. ASIA PACIFIC NEWBORN SCREENING MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)
FIGURE 19. CHINA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 20. INDIA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 21. JAPAN NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 22. AUSTRALIA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 23. SOUTH KOREA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLIONS)
FIGURE 24. REST OF ASIA PACIFIC NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 25. INDUSTRY PLAYER POSITIONING IN 2018 (IN %)


【掲載企業】

1. SCIEX
2. BIOTEK INSTRUMENTS INC.
3. BIO-RAD LABORATORIES INC.
4. CARDINAL HEALTH INC.
5. GE HEALTHCARE LIMITED
6. AGILENT TECHNOLOGIES INC.
7. MASIMO CORPORATION
8. NATUS MEDICAL INCORPORATED
9. MEDTRONIC PLC
10. THERMO FISHER SCIENTIFIC INC.
11. NEOGEN LABS PVT. LTD.
12. PERKINELMER INC.
13. ZENTECH S.A.
14. WATERS CORPORATION
15. TRIVITRON HEALTHCARE


【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 新生児スクリーニングのアジア太平洋市場予測2019-2027(ASIA PACIFIC NEW BORN SCREENING MARKET FORECAST 2019-2027)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆